Combined treatment of mice bearing HER2-expressing xenografts by trastuzumab and Affibody-mediated PNA-based pretargeting improves their survivalShow others and affiliations
2021 (English)In: European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, E-ISSN 1619-7089, Vol. 48, no SUPPL 1, p. S158-S158Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
SPRINGER , 2021. Vol. 48, no SUPPL 1, p. S158-S158
National Category
Radiology, Nuclear Medicine and Medical Imaging
Identifiers
URN: urn:nbn:se:kth:diva-307135ISI: 000709355000252OAI: oai:DiVA.org:kth-307135DiVA, id: diva2:1629950
Note
QC 20220119
2022-01-192022-01-192022-06-25Bibliographically approved